Document is current
Any future updates will be listed below
-
Authors
Antikainen, Anni A.
Mutter, Stefan
Harjutsalo, Valma
Thorn, Lena M.
Groop, Per-Henrik
Sandholm, Niina
,
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 27 September 2024
Accepted: 13 November 2024
First Online: 26 November 2024
Declarations
:
: The study was approved by the Ethics Committee of the Helsinki and Uusimaa Hospital District (491/E5/2006, 238/13/03/00/2015, HUS-3313-2018), and performed in accordance with the Declaration of Helsinki, with written informed consent obtained from the participants.
: Not applicable.
: S.M. received a lecture honorarium from Encore Medical Education. P.-H.G. has received investigator-initiated research grants from Eli Lilly and Roche, is an advisory board member for AbbVie, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Cebix, Eli Lilly, Janssen, Medscape, Merck Sharp & Dohme, Mundipharma, Nestlé, Novartis, Novo Nordisk and Sanofi; and has received lecture fees from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Merck Sharp & Dohme, Medscape, Novartis, Novo Nordisk, PeerVoice and Sanofi.
